McKesson to retain top wholesaler position following FTC decision on mergers.
This article was originally published in The Tan Sheet
Executive Summary
MCKESSON WOULD RETAIN NUMBER ONE WHOLESALER POSITION following the Federal Trade Commission's March 3 vote to oppose the two pending wholesaler mergers. The leading U.S. drug wholesaler successfully forced a tandem review of its merger with AmeriSource and the proposed merger of Cardinal Health and Bergen Brunswig. McKesson announced its agreement with AmeriSource shortly after the Cardinal/Bergen deal was unveiled.